NCT07676890 A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After Surgery Status NOT_YET_RECRUITING Phase PHASE1
NCT07673861 Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients Status RECRUITING Phase NA
NCT07673835 Iparomlimab and Tuvonralimab Plus Chemotherapy as Neoadjuvant Therapy for Ovarian Cancer(Phase II) Status NOT_YET_RECRUITING Phase PHASE2
NCT07670962 Blood-Based Minimal Residual Disease in Advanced Epithelial Ovarian Cancer After 1st Line Therapy Status NOT_YET_RECRUITING Phase N/A
NCT07670312 Evaluation of XYA02 in Patients With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07665515 Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status RECRUITING Phase PHASE1
NCT07664735 A Phase 1 Study to Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer. Status NOT_YET_RECRUITING Phase PHASE1
NCT07660718 The Use of Artificial Intelligence for Ultrasound Screening of Ovarian Cancer in Postmenopausal Women Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07657416 NK521 in the Treatment of Advanced Solid Tumors Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07651020 The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors Status COMPLETED Phase N/A
NCT07648745 Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian Cancer Status COMPLETED Phase PHASE2
NCT07647653 Fluzoparib + Bevacizumab vs Olaparib + Bevacizumab for Maintenance Therapy in HRD-Positive Advanced Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07642791 Safety of Opportunistic Salpingectomy During Elective Laparoscopic Cholecystectomy. Status ACTIVE_NOT_RECRUITING Phase NA
NCT07639801 68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors Status NOT_YET_RECRUITING Phase NA
NCT07637851 Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07634094 Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07613723 A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies Status RECRUITING Phase PHASE1